Showing 1 - 20 results of 3,809 for search '"Human Vaccines & Immunotherapeutics"', query time: 0.17s Refine Results
  1. 1
    A time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India

    A time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India by G. Alekhya, Prajna Paramita Giri, Arjun M.C., Binod Kumar Behera, Sonu Hangma Subba

    Published 2022-11-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  2. 2
    Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3 Salmonella in mice

    Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3 Salmonella in mice by Fabien J. Fuche, Jennifer A. Jones, Girish Ramachandran, Ellen E. Higginson, Raphael Simon, Sharon M. Tennant

    Published 2019-06-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  3. 3
    Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

    Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults by Felicia Scaggs Huang, David I. Bernstein, Karen S. Slobod, Allen Portner, Toru Takimoto, Charles J. Russell, Michael Meagher, Bart G. Jones, Robert E. Sealy, Christopher Coleclough, Kristen Branum, Michelle Dickey, Kristen Buschle, Monica McNeal, Mat Makowski, Aya Nakamura, Julia L. Hurwitz

    Published 2021-02-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  4. 4
    Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies

    Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies by Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Talha Bin Emran, Ali A. Rabaan, Abbas Al Mutair

    Published 2021-10-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  5. 5
    Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

    Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction by Yongji Wang, Yangyang Qi, Wenguo Xu, Yuansheng Hu, Ling Wang, Yongpei Yu, Zhiwei Jiang, Jielai Xia, Gang Zeng, Yalong Wang

    Published 2020-10-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  6. 6
    Human Vaccines & Immunotherapeutics: News

    Human Vaccines & Immunotherapeutics: News

    Published 2019-05-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  7. 7
    A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam

    A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU... by Phan Trong Lan, Nguyen Trong Toan, Hoang Anh Thang, Tran Cong Thang, Le Van Be, Duong Huu Thai, Vu Minh Huong, Nguyen Tuyet Nga, Yuxiao Tang, Renee Holt, Berlanda Scorza Francesco, Jorge Flores, Tushar Tewari

    Published 2019-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  8. 8
    Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

    Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or... by Stephanie Pepin, Jean-François Nicolas, Henryk Szymanski, Isabel Leroux-Roels, Thomas Schaum, Marc Bonten, Giancarlo Icardi, Anju Shrestha, Cynthia Tabar, The QHD00011 study team

    Published 2021-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  9. 9
    Introduction to special issue: International Society for Vaccines Annual Congress 2016

    Introduction to special issue: International Society for Vaccines Annual Congress 2016 by Margaret A. Liu, Shan Lu

    Published 2017-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  10. 10
    A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial

    A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial by Li Zhang, Pengfei Jin, Mingwei Wei, Hudachuan Jiang, Jingxin Li, Fengcai Zhu

    Published 2022-11-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  11. 11
    Coverage of HPV-Related Information on Chinese Social Media: a Content Analysis of Articles in Zhihu

    Coverage of HPV-Related Information on Chinese Social Media: a Content Analysis of Articles in Zhihu by Jinhui Li, Han Zheng

    Published 2020-10-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  12. 12
    Non-specific effects of vaccinations in high-income settings: How to address the issue?

    Non-specific effects of vaccinations in high-income settings: How to address the issue? by Alberto Donzelli, Alessandro Schivalocchi, Giulia Giudicatti

    Published 2018-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  13. 13
    Challenges and opportunities for meningococcal vaccination in the developing world

    Challenges and opportunities for meningococcal vaccination in the developing world by Rouba Shaker, Danielle Fayad, Ghassan Dbaibo

    Published 2018-05-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  14. 14
    Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development

    Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development by Kranti Suresh Vora, Aarthi Sundararajan, Shahin Saiyed, Kuldeep Dhama, Senthilkumar Natesan

    Published 2020-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  15. 15
    Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States

    Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States by Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Marieke Heisen, Jessica Weaver, Kristen A. Feemster, Bianca Chun, Thomas W. Weiss, Jordana K Schmier

    Published 2024-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  16. 16
    The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages

    The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages by Paolo Bonanni, Giampietro Chiamenti, Giorgio Conforti, Tommasa Maio, Anna Odone, Rocco Russo, Silvestro Scotti, Carlo Signorelli, Alberto Villani, The Scientific Board of “Lifetime Immunization Schedule”

    Published 2017-11-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  17. 17
    Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines

    Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococc... by Leonardo Terranova, Nicola Principi, Sonia Bianchini, Giada Di Pietro, Giulia Umbrello, Barbara Madini, Susanna Esposito

    Published 2018-05-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  18. 18
    HV&I reviewer highlight

    HV&I reviewer highlight by Ronald Ellis, Adam Weiss

    Published 2023-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  19. 19
    Early approval of COVID-19 vaccines: Pros and cons

    Early approval of COVID-19 vaccines: Pros and cons by Md Arifur Rahman, Md Sayeedul Islam

    Published 2021-10-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
  20. 20
    Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19

    Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19 by Pasquale Stefanizzi, Francesco Paolo Bianchi, Giuseppe Spinelli, Fabio Amoruso, Domenica Ancona, Paolo Stella, Silvio Tafuri

    Published 2022-01-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article

Search Tools: